Skip to search formSkip to main contentSkip to account menu

solifenacin succinate 5 MG Oral Tablet [Vesicare]

Known as: SOLIFENACIN SUCCINATE 5 mg ORAL TABLET, FILM COATED [VESIcare], VESIcare 5 MG Oral Tablet 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Introduction and hypothesisTo determine the effectiveness of the muscarinic receptor antagonist solifenacin (VESIcare®) in the… 
2016
2016
Background Radiotherapy is explicitly indicated as one of the excluding factors in diagnosing overactive bladder syndrome (OAB… 
2014
2014
PURPOSE Permanent and prolonged incontinence following robot assisted radical prostatectomy (RARP) is known to result from injury… 
2004
2004
ObjectiveSolifenacin succinate (YM905; Vesicare®) is a promising new bladder selective muscarinic receptor antagonist under…